BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 33127503)

  • 1. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
    Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
    J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
    Tandon M; Kataria S; Patel J; Mehta TR; Daimee M; Patel V; Prasad A; Chowdhary AA; Jaiswal S; Sriwastava S
    Int J Infect Dis; 2021 Mar; 104():390-397. PubMed ID: 33434662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
    J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
    Paterson RW; Benjamin LA; Mehta PR; Brown RL; Athauda D; Ashton NJ; Leckey CA; Ziff OJ; Heaney J; Heslegrave AJ; Benedet AL; Blennow K; Checkley AM; Houlihan CF; Mummery CJ; Lunn MP; Manji H; Zandi MS; Keddie S; Chou M; Vinayan Changaradil D; Solomon T; Keshavan A; Barker S; Jäger HR; Carletti F; Simister R; Werring DJ; Spyer MJ; Nastouli E; Gauthier S; Rosa-Neto P; ; Zetterberg H; Schott JM
    Brain Commun; 2021; 3(3):fcab099. PubMed ID: 34396099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
    Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
    Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
    Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
    Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies.
    Zamani R; Pouremamali R; Rezaei N
    Rev Neurosci; 2022 Jun; 33(4):397-412. PubMed ID: 34536341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings.
    Paterson RW; Brown RL; Benjamin L; Nortley R; Wiethoff S; Bharucha T; Jayaseelan DL; Kumar G; Raftopoulos RE; Zambreanu L; Vivekanandam V; Khoo A; Geraldes R; Chinthapalli K; Boyd E; Tuzlali H; Price G; Christofi G; Morrow J; McNamara P; McLoughlin B; Lim ST; Mehta PR; Levee V; Keddie S; Yong W; Trip SA; Foulkes AJM; Hotton G; Miller TD; Everitt AD; Carswell C; Davies NWS; Yoong M; Attwell D; Sreedharan J; Silber E; Schott JM; Chandratheva A; Perry RJ; Simister R; Checkley A; Longley N; Farmer SF; Carletti F; Houlihan C; Thom M; Lunn MP; Spillane J; Howard R; Vincent A; Werring DJ; Hoskote C; Jäger HR; Manji H; Zandi MS
    Brain; 2020 Oct; 143(10):3104-3120. PubMed ID: 32637987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
    Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
    J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
    Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
    J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.